Atlas Trials

Anaplastic Lymphoma Kinase-positive

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Anaplastic Lymphoma Kinase-positive

RecordFirmDate
A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors (NCT03546894)Takeda2018-07-23

Track Anaplastic Lymphoma Kinase-positive automatically

Every clearance here is in the API, with alerts when new ones post.